United States In Vitro Diagnostics Market to Grow at 5.0% CAGR, Reaching USD 131.68 billion by 2032, Led by Roche, Abbott, and Siemens Healthineers | DataM Intelligence

The global In Vitro Diagnostics Market reached USD 84.90 billion in 2024 and is projected to reach USD 131.68 billion by 2032, growing at a CAGR of 5.0% during the forecast period 2025-2032, according to DataM Intelligence.

United States: Recent Industry Developments

✅ In October 2023, Roche Diagnostics launched the cobas® pro integrated solutions in the U.S., enhancing automation in clinical chemistry and immunotesting.
✅ In October 2023, Abbott Laboratories received FDA clearance for its Alinity® s HIV combo assay, expanding its infectious disease testing portfolio.
✅ In October 2023, Quest Diagnostics partnered with a major health system to implement AI-powered diagnostic algorithms for early cancer detection.

Japan: Recent Industry Developments

✅ In October 2023, Sysmex Corporation launched the XN-9100 hematology analyzer series with enhanced AI-based morphological analysis capabilities.
✅ In October 2023, Fujirebio received PMDA approval for its new automated chemiluminescent enzyme immunoassay system for cancer biomarker testing.
✅ In October 2023, Toshiba Corporation partnered with leading Tokyo research institutes to develop next-generation molecular diagnostics for early cancer detection.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/in-vitro-diagnostics-market?jd

Market Trends & Drivers

The In Vitro Diagnostics Market is experiencing significant growth driven by the rising prevalence of chronic diseases, increasing demand for point-of-care testing, and technological advancements in molecular diagnostics. Key trends include the integration of artificial intelligence in diagnostic interpretation, the shift toward decentralized testing, and the growing emphasis on personalized medicine. The expanding geriatric population, increased healthcare spending, and post-pandemic focus on diagnostic infrastructure are significantly accelerating market demand across all testing categories.

Competitive Landscape

The market features intense competition among global diagnostics companies, specialized technology firms, and emerging players in digital diagnostics.

Roche Diagnostics leads the IVD market with its integrated cobas® systems and extensive portfolio in molecular diagnostics and immunoassays.
Abbott Laboratories dominates in rapid diagnostics and point-of-care testing with its Alinity® system portfolio and BinaxNOW® platforms.
Siemens Healthineers is a major player in laboratory automation and immunoassay systems with its Atellica® Solution.
Danaher Corporation (through Beckman Coulter and Cepheid) provides comprehensive solutions in molecular diagnostics and laboratory automation.
Thermo Fisher Scientific offers a broad range of IVD reagents, instruments, and test kits for clinical laboratories.
Sysmex Corporation specializes in hematology analyzers and urinalysis systems for clinical laboratories.
Bio-Rad Laboratories provides quality controls, infectious disease testing, and autoimmune testing solutions.
Becton, Dickinson and Company (BD) focuses on microbiology and molecular diagnostics systems.
bioMérieux SA is a leader in microbiology and infectious disease diagnostics.
Qiagen N.V. provides sample preparation technologies and molecular diagnostic tests.

Segmentation

By Product Type (Instruments, Reagents, Software and Services, Others)
By Technique Type (Immunoassays, POC Diagnostics, Molecular Diagnostics, Hematology, Tissue Diagnostics, Microbiology, Self-Blood-Glucose Monitoring, Others)
By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, Drug Testing, Others)
By End-User (Diagnostic Laboratories, Hospitals, Academics and Research Institutes, Others)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/in-vitro-diagnostics-market?jd

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (Germany, U.K., France, Italy, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us:
DataM Intelligence is a market research and consulting firm that bridges the gap between data and decisive action. We specialize in translating top market trends and in-depth analysis into swift, smart solutions for your business.
With a repository of 6,300+ reports across 40+ industries, we provide the robust intelligence that over 200 companies in 50+ countries rely on to power their growth.

This release was published on openPR.